User menu

A systematic review of the predictive value of (18) F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation

Bibliographic reference Krug, Bruno ; Crott, Ralph ; de Canniere, Louis ; D'Hondt, Lionel ; Vander Borght, Thierry. A systematic review of the predictive value of (18) F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation. In: Colorectal Disease, Vol. 15, no. 11, p. e627-e633 (2013)
Permanent URL
  1. Sole C., Russo M., Ovalle V., Rivera R., Sole S., Frelinghuysen M., Baeza M., 6052 POSTER Preoperative Radio-chemotherapy in Locally Advanced Rectal Cancer – Prognostic Value of Time Interval to Surgery on Cancer Specific Survival, 10.1016/s0959-8049(11)71697-5
  2. Maas Monique, Rutten Iris J. G., Nelemans Patty J., Lambregts Doenja M. J., Cappendijk Vincent C., Beets Geerard L., Beets-Tan Regina G. H., What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : Imaging for recurrent colorectal cancer, 10.1007/s00259-011-1785-1
  3. Shivnani Anand T., Small William, Stryker Steven J., Kiel Krystyna D., Lim Sherry, Halverson Amy L., Talamonti Mark S., Preoperative chemoradiation for rectal cancer: results of multimodality management and analysis of prognostic factors, 10.1016/j.amjsurg.2006.09.030
  4. Zhu Aizhi, Lee Daniel, Shim Hyunsuk, Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response, 10.1053/j.seminoncol.2010.11.012
  5. Suttie S.A., Welch A.E., Park K.G.M., Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma, 10.1016/j.ejso.2009.01.012
  6. Smyth Elizabeth C, Role of (18F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies, 10.3748/wjg.v17.i46.5059
  7. Schwarz J. K., Grigsby P. W., Dehdashti F., Delbeke D., The Role of 18F-FDG PET in Assessing Therapy Response in Cancer of the Cervix and Ovaries, 10.2967/jnumed.108.057257
  8. Gupta Tejpal, Master Zubin, Kannan Sadhana, Agarwal Jai Prakash, Ghsoh-Laskar Sarbani, Rangarajan Venkatesh, Murthy Vedang, Budrukkar Ashwini, Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis, 10.1007/s00259-011-1893-y
  9. Erasmus J. J., Rohren E., Swisher S. G., Prognosis and Reevaluation of Lung Cancer by Positron Emission Tomography Imaging, 10.1513/pats.200806-059lc
  10. Delbeke Dominique, Martin William H., FDG PET and PET/CT for Colorectal Cancer, Methods in Molecular Biology (2011) ISBN:9781617790614 p.77-103, 10.1007/978-1-61779-062-1_6
  11. Chessin David B., Kiran Ravi P., Akhurst Timothy, Guillem Jose G., The Emerging Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Primary and Recurrent Rectal Cancer, 10.1016/j.jamcollsurg.2005.06.277
  12. de Geus-Oei L.-F., Vriens D., van Laarhoven H. W.M., van der Graaf W. T.A., Oyen W. J.G., Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review, 10.2967/jnumed.108.057224
  13. Evans Jessica, Patel Uday, Brown Gina, Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy, 10.1016/j.semradonc.2011.02.002
  14. Minsky Bruce D., Unique Considerations in the Patient With Rectal Cancer, 10.1053/j.seminoncol.2011.05.008
  15. Pricolo Victor E., Rectal Cancer: The Good, the Bad, and the Ugly : Comment on “Determining the Need for Radical Surgery in Patients with T1 Rectal Cancer ”, 10.1001/archsurg.2011.71
  16. Vriens, Q J Nucl Med Mol Imaging, 53, 224 (2009)
  17. Søreide K., Traeland J. H., Stokkeland P. J., Glomsaker T., Søreide J. A., Kørner H., Adherence to national guidelines for surveillance after curative resection of nonmetastatic colon and rectum cancer: a survey among Norwegian gastrointestinal surgeons : Adherence to national guidelines for surveillance, 10.1111/j.1463-1318.2011.02631.x
  18. Samee Abdus, Current trends in staging rectal cancer, 10.3748/wjg.v17.i7.828
  19. Mijnhout G. Sophie, Riphagen Ingrid I., Hoekstra Otto S., Update of the FDG PET search strategy : , 10.1097/00006231-200412000-00006
  20. Whiting P, Rutjes A, Dinnes J, Reitsma J, Bossuyt P, Kleijnen J, Development and validation of methods for assessing the quality of diagnostic accuracy studies, 10.3310/hta8250
  21. Whiting Penny, Rutjes Anne WS, Reitsma Johannes B, Bossuyt Patrick MM, Kleijnen Jos, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, 10.1186/1471-2288-3-25
  22. Whiting Penny F, Weswood Marie E, Rutjes Anne WS, Reitsma Johannes B, Bossuyt Patrick NM, Kleijnen Jos, Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies, 10.1186/1471-2288-6-9
  23. Parmar Mahesh K. B., Torri Valter, Stewart Lesley, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>;2-8
  24. Tierney Jayne F, Stewart Lesley A, Ghersi Davina, Burdett Sarah, Sydes Matthew R, Practical methods for incorporating summary time-to-event data into meta-analysis, 10.1186/1745-6215-8-16
  25. Higgins J. P T, Measuring inconsistency in meta-analyses, 10.1136/bmj.327.7414.557
  26. Higgins Kristin A., Willett Christopher G., Czito Brian G., Nonoperative Management of Rectal Cancer: Current Perspectives, 10.3816/ccc.2010.n.011
  27. Calvo Felipe A, Domper Marta, Matute Raúl, Martínez-Lázaro Raúl, Arranz José A, Desco Manuel, Álvarez Emilio, Carreras José Luis, 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation, 10.1016/j.ijrobp.2003.09.058
  28. Capirci Carlo, Rubello Domenico, Chierichetti Franca, Crepaldi Giorgio, Fanti Stefano, Mandoliti Giovanni, Salviato Simonetta, Boni Giuseppe, Rampin Lucia, Polico Cesare, Mariani Giuliano, Long-Term Prognostic Value of18F-FDG PET in Patients with Locally Advanced Rectal Cancer Previously Treated with Neoadjuvant Radiochemotherapy, 10.2214/ajr.05.0902
  29. Martoni A. A., Di Fabio F., Pinto C., Castellucci P., Pini S., Ceccarelli C., Cuicchi D., Iacopino B., Di Tullio P., Giaquinta S., Tardio L., Lombardi R., Fanti S., Cola B., Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer, 10.1093/annonc/mdq433
  30. Nakagawa Keiichi, Yamashita Hideomi, Nakamura Naoki, Igaki Hiroshi, Tago Masao, Hosoi Yoshio, Momose Toshimitsu, Ohtomo Kuni, Muto Tetsuichiro, Nagawa Hirokazu, Preoperative Radiation Response Evaluated by 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival in Locally Advanced Rectal Cancer : , 10.1007/s10350-008-9243-2
  31. Yeung J. M. C., Kalff V., Hicks R. J., Drummond E., Link E., Taouk Y., Michael M., Ngan S., Lynch A. C., Heriot A. G., Metabolic Response of Rectal Cancer Assessed by 18-FDG PET Following Chemoradiotherapy is Prognostic for Patient Outcome : , 10.1007/dcr.0b013e31820b36f0
  32. Ruby Jeannine A., Leibold Tobias, Akhurst Timothy J., Shia Jinru, Saltz Leonard B., Mazumdar Madhu, Riedel Elyn R., Larson Steven M., Guillem José G., FDG-PET Assessment of Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Is Not Associated With Long-Term Prognosis : A Prospective Evaluation, 10.1097/dcr.0b013e318244a666